Header Logo

Connection

ALEJANDRO ARBOLEDA to Spironolactone

Back to Details
This is a "connection" page, showing publications ALEJANDRO ARBOLEDA has written about Spironolactone.
ALEJANDRO ARBOLEDA
Connection Strength
0.149
Spironolactone
  1. Mineralocorticoid receptor antagonism limits experimental choroidal neovascularization and structural changes associated with neovascular age-related macular degeneration. Nat Commun. 2019 01 21; 10(1):369.
    View in: PubMed
    Score: 0.149
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.